Results 151 to 160 of about 7,804 (207)

Drospirenone/ethinyl estradiol

Drugs of Today, 2008
Drospirenone 3 mg/ethinyl estradiol 20 microg (24/4) is a new unique oral contraceptive formulation that combines in a novel dosing regimen the lowest dosage of ethinyl estradiol commonly used today with drospirenone, an innovative progestin.
Andrea J, Rapkin, Shelley N, Sorger, Sharon A, Winer   +2 more
openaire   +2 more sources

The use of ethinyl estradiol in pregnancy

American Journal of Obstetrics and Gynecology, 1952
Abstract 1. 1. A standard dosage schedule of ethinyl estradiol, 0.5 mg. three times a day during pregnancy, will yield excellent fetal salvage with patients who have had previous abortions. 2. 2. This standard dosage schedule of ethinyl estradiol did not materially reduce the incidence of toxemia of pregnancy. 3. 3.
C H, BIRNBERG, L J, BRANDMAN, B, GREENBLAT   +2 more
openaire   +2 more sources

SUPPRESSION OF LACTATION WITH ETHINYL ESTRADIOL

The Journal of Clinical Endocrinology & Metabolism, 1948
THE estrogens have proved their usefulness in the control of painful breast engorgement in the immediate postpartum period and in the early suppression of lactation. However, the ideal product, dosage and time of administration have not been reached.
D B, GERSHENFELD, I K, PERLMUTTER
openaire   +2 more sources

THE METABOLISM OF ETHINYL ESTRADIOL IN MAN*

The Journal of Clinical Endocrinology & Metabolism, 1951
IN REVIEWING the literature on ethinyl estradiol, Thompson has pointed out that despite the increasing clinical use of this orally potent estrogen, there is a relative paucity of information on the more subtle details of its fate in the various parts of the body, such as its site of inactivation, degradation products, path of excretion, and effect on ...
B F, STIMMEL, J A, MAY, J A, RANDOLPH, W M, CONN   +3 more
openaire   +2 more sources

Oral therapy with ethinyl estradiol in the menopause

American Journal of Obstetrics and Gynecology, 1946
T HE value of estrogenic preparations in the treatment of the menopausal syndrome is firmly established. Ever since chemically pure estrogens became available, the medical profession has sought earnestly for compounds which, when given orally, have the distinction of high potency, good tolerability, and economy.
H, WIESBADER, W, FILLER
openaire   +2 more sources

Ethinyl estradiol in the treatment of metrorrhagia

American Journal of Obstetrics and Gynecology, 1946
Abstract Irregular bleeding, acyclic bleeding from the uterus, must first be classified according to etiology. Approximately one-half of the patients seen in private practice with this complaint have an organic basis for that bleeding. The other half bleed from the uterus as a result of abnormal physiology in the pituitary-ovarian endometrium cycle ...
openaire   +2 more sources

Ethinyl Estradiol: A Clinical Evaluation

The Journal of Clinical Endocrinology & Metabolism, 1942
The quest for an orally effective estrogen has occupied the attention of chemists for the past decade. This search has been greatly accelerated during the past few years, and remarkable resultshave been obtained, particularly in the production of non-Steroid compounds that possess great estrogenic activity.
Morris J. Groper, Gerson R. Biskind
openaire   +1 more source

Choice of ethinyl estradiol as a postcoital pill

American Journal of Obstetrics and Gynecology, 1973
In the article "Interception: The use of postovulatory estrogens to prevent implantation" (Am. J. Obstet. Gynecol. 115: 101 1973) Morris and van Wagenen show that postovulatory administration of estrogens in a high dosage seems to be an effective method of lowering the pregnancy rate to the .3 to .03 per cent range after unprotected intercourse. They
openaire   +2 more sources

Fluorometric Determination of Ethinyl Estradiol in Tablets

Journal of Pharmaceutical Sciences, 1972
A fluorometric procedure, based on the Liebermann-Burchard reaction, was developed for assaying ethinyl estradiol in tablets. A chloroform extract of ethinyl estradiol is reacted with acetic anhydride and sulfuric acid, and the resulting fluorophor is measured at 400 nm. while exciting at 324 nm. Fluorescence versus concentration is linear up to 10 mcg.
openaire   +2 more sources

ETHINYL ESTRADIOL

Obstetrical & Gynecological Survey, 1947
Charles H. Birnberg, Seymour H. Livingston, Lawrence Kurzrok, Daniel A. Sherber   +3 more
openaire   +2 more sources